FSHD

Clinical trials for FSHD explained in plain language.

Never miss a new study

Get alerted when new FSHD trials appear

Sign up with your email to follow new studies for FSHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug aims to build muscle in rare muscular dystrophy

Disease control Not yet recruiting

This Phase 2 study tests a drug called apitegromab in 60 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes muscle weakness. Participants will receive either the drug or a placebo every 4 weeks for a year. The main goal is to see if the dru…

Matched conditions: FSHD

Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

FSHD

Get alerted when new FSHD trials appear

New drug aims to build muscle in rare muscular dystrophy